[Federal Register Volume 74, Number 10 (Thursday, January 15, 2009)]
[Notices]
[Page 2620]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-730]



[[Page 2620]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated September 18, 2008, and published in the Federal 
Register on September 26, 2008, (73 FR 55869), Mallinckrodt Inc., 3600 
North Second Street, St. Louis, Missouri 63147, made application by 
letter to the Drug Enforcement Administration (DEA) to be registered as 
a bulk manufacturer of Oripavine (9330), a basic class of controlled 
substance listed in schedule II.
    The company plans to use the above listed controlled substance as 
an intermediate in the manufacture of a non-controlled product.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Mallinckrodt Inc. to manufacture the listed basic class of controlled 
substance is consistent with the public interest at this time. DEA has 
investigated Mallinckrodt Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the 
above named company is granted registration as a bulk manufacturer of 
the basic class of controlled substance listed.

    Dated: January 9, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-730 Filed 1-14-09; 8:45 am]
BILLING CODE 4410-09-P